Bakker Juliet Tammenoms
CIK 1431159 · last filed 2026-06-18
Bakker Juliet Tammenoms is a corporate insider who has filed 57 SEC Form 4 insider transactions across 15 companies since 2011. The most recent filing, for RXST, was dated Jun 18, 2026. Across all open-market trades the lifetime net is +$193.7M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.62B across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.62B
15
57
$193.75M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RXST | Director | 86,731 | $6.01 | $521.3K | -$13.82M | 18 | 2026-06-18 |
| CBLL | Director | 2,498,394 | $17.69 | $44.20M | $4.03M | 3 | 2026-06-04 |
| VERA | 10%+ Owner | 3,429,927 | $32.10 | $110.10M | $60.00M | 1 | 2023-02-08 |
| Sierra Oncology, Inc. (SRRA) Delisted | 10%+ Owner | 175,000 | $54.99 | $9.62M | $28.35M | 3 | 2022-02-02 |
| RPID | 10%+ Owner | 150,000 | $2.13 | $319.5K | $18.00M | 1 | 2021-07-20 |
| Eargo, Inc. (EAR) Delisted | Director | 96,286 | $2.57 | $247.5K | $4.20M | 4 | 2021-05-19 |
| Tourmaline Bio, Inc. (TALS) Delisted | 10%+ Owner | 322,078 | $27.20 | $8.76M | $15.98M | 1 | 2021-05-11 |
| Axonics, Inc. (AXNX) Delisted | Director | 1,958,833 | $70.98 | $139.04M | $7.51M | 9 | 2020-09-22 |
| Molecular Templates, Inc. (MTEM) Delisted | 10%+ Owner | 0 | $0.00 | $0 | $29.85M | 2 | 2020-09-01 |
| Venus Concept Inc. (HAIR) Delisted | Director | 231,772 | — | — | $0 | 1 | 2019-11-07 |
| Tricida, Inc. (TCDA) Delisted | 10%+ Owner | 3,019,734 | $0.11 | $326.1K | $10.00M | 1 | 2018-07-02 |
| Aptinyx Inc. (APTX) Delisted | 10%+ Owner | 3,190,079 | $0.06 | $194.6K | $7.20M | 1 | 2018-06-26 |
| COLL | 10%+ Owner | 6,029,785 | $35.39 | $213.39M | $12.30M | 2 | 2018-02-26 |
| CORT | Director | 10,874,259 | $114.49 | $1.24B | $11.70M | 4 | 2016-12-19 |
| ESPR | 10%+ Owner | 1,883,769 | $3.18 | $5.99M | -$1.55M | 2 | 2014-10-14 |
Recent Filings
57 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-18 | RXST | Grant (A) | +37,037 | $0 | EDGAR |
| 2026-06-04 | CBLL | Grant (A) | +7,838 | $0 | EDGAR |
| 2025-06-17 | CBLL | Grant (A) | +8,828 | $0 | EDGAR |
| 2025-06-04 | RXST | Grant (A) | +10,752 | $0 | EDGAR |
| 2024-10-16 | CBLL | Mixed | +2,384,452 | $4.03M | EDGAR |
| 2024-06-10 | RXST | Grant (A) | +2,554 | $0 | EDGAR |
| 2024-05-21 | RXST | Buy (P) | +5,000 | $305.5K | EDGAR |
| 2024-02-15 | RXST | Buy (P) | +8,000 | $406.7K | EDGAR |
| 2023-11-30 | RXST | Mixed | −937,403 | -$14.70M | EDGAR |
| 2023-11-16 | RXST | Sell (S) | −500,000 | -$13.59M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.